Results 221 to 230 of about 26,327 (353)

Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
Insulin resistance in heart failure with mildly reduced or preserved ejection fraction: insights from FINEARTS‐HF. CI, confidence interval; CV, cardiovascular; eGDR, estimated glucose disposal rate; HF, heart failure. Aims The estimated glucose disposal rate (eGDR) is a simple, non‐invasive measure of insulin resistance. In this exploratory analysis of
John W. Ostrominski, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Katja Rohwedder, Meike Brinker, Patrick Schloemer, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan   +15 more
wiley   +1 more source

Predicting cardiac and renal responses to sacubitril/valsartan with a mathematical model of heart failure with preserved ejection fraction. [PDF]

Am J Physiol Heart Circ Physiol
Clemmer JS, Hall ME, Mallette JH, Pruett WA.   +3 more
europepmc   +1 more source

Changes with Age in the Activities of β‐Secretase and the Aβ‐Degrading Enzymes Neprilysin, Insulin‐Degrading Enzyme and Angiotensin‐Converting Enzyme

, 2010
J. Scott Miners, Zoë Van Helmond, Patrick G. Kehoe, Seth Love   +3 more
openalex   +2 more sources

Correction: Corrigendum: N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin [PDF]

, 2016
A. Ian Smith, Niwanthi W. Rajapakse, Oded Kleifeld, Bruno Lomonte, Nkumbu L. Sikanyika, Alexander James Spicer, Wayne C. Hodgson, Paul J. Conroy, David H. Small, David M. Kaye, Helena C. Parkington, James C. Whisstock, Sanjaya Kuruppu   +12 more
openalex   +1 more source

Nationwide implementation of heart failure therapies: National Heart Failure Center Accreditation Program (HF‐CAP) in China

European Journal of Heart Failure, EarlyView.
Nationwide implementation of heart failure therapies in China. ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; CI, confidence interval; CV, cardiovascular; GDMT, guideline‐directed medical therapy; HF, heart failure; HF‐CAP, National Heart Failure Center Accreditation ...
Jingmin Zhou, Xuejuan Jin, Yamei Xu, Zhonglei Xie, Xiaotong Cui, Yanyan Wang, Hua Wang, Xinli Li, Yugang Dong, Yuhua Liao, Weimin Li, Alexandre Mebazaa, Jiefu Yang, Junbo Ge, on behalf of the Heart Failure Center Accreditation Program Investigators   +14 more
wiley   +1 more source

Assessment of Cognitive Function via Biomarkers in Japanese Patients With Chronic Heart Failure Treated With Angiotensin-Receptor-Neprilysin Inhibitor. [PDF]

Circ Rep
Kogure M, Kitani-Morii F, Kitani T, Oishi M, Shiraishi H, Tatebe H, Matoba S, Tokuda T, Kasai T.   +8 more
europepmc   +1 more source

European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure

European Journal of Heart Failure, EarlyView.
The patient with SMR: From diagnostic assessment to treatment. Secondary mitral regurgitation (SMR) is highly prevalent in patients with heart failure (HF), associated with poor prognosis, and its treatment is typically preceded by implementing pharmacotherapy for HF as well as cardiac resynchronization therapy.
Christos Iliadis, Marianna Adamo, Volker Rudolph, Nicole Karam, Ralph Stephan von Bardeleben, Stefan D. Anker, Victoria Delgado, Jörg Hausleiter, Hannah Kempton, Marco Metra, Michael Böhm, Stephan Baldus   +11 more
wiley   +1 more source

Improving the Management of Patients with Heart Failure with Reduced Ejection Fraction in Clinical Practice: The Case for Angiotensin Receptor-Neprilysin Inhibitor. [PDF]

Card Fail Rev
Iacoviello M, Maria Sarullo F, Bilato C, Correale M, Di Gesaro G, Driussi M, Passantino A, Villani A, Di Lenarda A.   +8 more
europepmc   +1 more source

Epigenetic suppression of neprilysin regulates breast cancer invasion [PDF]

, 2016
Hannah Stephen, Rachil Khoury, Parth R. Majmudar, T Blaylock, Kathleen A. Hawkins, M S Salama, M. D. Scott, B Cosminsky, Nipun Utreja, Jon Britt, Rebecca Conway   +10 more
openalex   +1 more source

Beta‐blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes

European Journal of Heart Failure, EarlyView.
In total, 5084 patients from Swedish registries with both heart failure (HF) with reduced ejection fraction (HFrEF) and chronic obstructive pulmonary disease (COPD) were included. Confounding was handled by overlap weighting based on propensity scores for beta‐blocker use. Patients were followed up for 5 years, or until death, emigration from Sweden or
Benedikt N. Beer, Lina Benson, Christian Basile, Benedikt Schrage, Peter Moritz Becher, Stefan Blankenberg, Paulus Kirchhof, Barna Szabó‐Söderberg, Marco Metra, Anne Lindberg, Egidio Imbalzano, Giuseppe M. C. Rosano, Patric Karlström, Peter G.M. Mol, Raffaele Scorza, Lars H. Lund, Felix Lindberg, Gianluigi Savarese   +17 more
wiley   +1 more source